Financing type:  underwritten prospectus offering

Gross proceeds:  $17,250,345

Offering:  4,107,225 listed shares with 2,053,612 warrants attached

Offering price:   $4.20 per listed share

Warrant exercise terms:  $5.65 per warrant for a three-year period

Overallotment option:  The underwriters may purchase a maximum of 535,725 listed shares and 267,862 warrants for overallotment purposes. As of Jan. 27, 2026, such option had been exercised in full and 535,725 listed shares and 267,862 warrants have been issued thereunder. All information presented herein includes such exercise.

Non-cash commissions:  236,458 warrants

Commission terms:  each non-transferable warrant is exercisable at $4.20 for a three-year period

Public disclosure:  refer to the prospectus supplement dated Jan. 14, 2026, and company's news release(s) dated Jan. 12, 2026, Jan. 14, 2026, and Jan. 27, 2026